Screening for aneuploidy in twin pregnancies: Maternal age- and race-specific risk assessment between 9-14 weeks

Twin Research

Volumn 6, Issue 4, 2003, Pages 251-256

  Odibo, Anthony O ^a   Elkousy, Mohammed H ^a   Ural, Serdar H ^a   Driscoll, Deborah A ^a   Mennuti, Michael T ^a   Macones, George A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CHORION VILLUS SAMPLING; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL AGE; PATIENT COUNSELING; PRENATAL SCREENING; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; TRISOMY 13; TRISOMY 18; TRISOMY 21; TWIN PREGNANCY;

ANEUPLOIDY; DISEASES IN TWINS; FEMALE; GENETIC SCREENING; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PREGNANCY; RISK ASSESSMENT; TWINS, DIZYGOTIC;

PIERINAE; POMACANTHUS MACULOSUS;

EID: 0041377652     PISSN: 13690523     EISSN: None     Source Type: Journal    
DOI: 10.1375/136905203322296566     Document Type: Article

References (23)

1. Cuckle, H. (1998). Down syndrome screening in twins. Journal of Medical Screening, 5, 3-4.
2. Hook, E. B., & Hamerton, J. H. (1977). The frequency of chromosomal abnormalities detected in consecutive newborn studies - Differences between studies - Results by sex and severity of involvement. In E. B. Hook, & I. H. Porter (Eds.), Population cytogenetic studies in humans (pp. 63-80). New York: Academic Press.
3. Hook, E. B. (1978). Rates of Down's syndrome in livebirths and at midtrimester amniocentesis. Lancet, 1, 1053-1054.
4. Hook, E. B. (1981). Rates of chromosomal abnormalities at different maternal ages. Obstetrics and Gynecology, 58, 282-285.
5. Hook, E. B., Cross, P. K., Jackson, L., Pergament, E., & Brambati, B. (1988). Maternal age-specific rates of 47, +21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: Comparison with rates expected from observations at amniocentesis. American Journal of Human Genetics, 42, 797-807.
6. Hook, E. B., Cross, P. K., & Schreinemachers, D. M. (1983). Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA, 249, 2034-2038.
7. Meyers, C., Adam, R., Dungan, J., & Prenger, V. (1997). Aneuploidy in twin gestations: When is maternal age advanced? Obstetrics and Gynecology, 89, 248-251.
8. Neveux, L. M., Palomaki, G. E., Knight, G. J., & Haddow, J. E. (1996). Multiple marker screening for Down syndrome in twin pregnancies. Prenatal Diagnosis, 16, 29-34.
9. O'Brien, J. E., Dvorin, E., Yaron, Y., Ayoub, M., Johnson, M. P., Hume, R. F., et al. (1997). Differential increase in AFP, hCG and uE3 in twin pregnancies: Impact on attempts to quantify Down syndrome calculations. American Journal of Medical Genetics, 73, 109-112.
10. Rodis, J. F., Egan, J. F. X., Craffey, A., Ciarleglio, L., Greenstein, R. M., & Scorza, W. E. (1990). Calculated risk of chromosomal abnormalities in twin gestations. Obstetrics and Gynecology 76, 1037-1041.
11. Sebire, N. J., Snijders, R. J. M., Hughes, K., Sepulveda, W., & Nicolaides, K. H. (1996). Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. British Journal of Obstetrics and Gynaecology, 103, 999-1003.
12. Sebire, N. J., Noble, P. L., Psarra, A., Papanagiotou, G., & Nicolaides, K. H. (1996). Fetal karyotyping in twin pregnancies: Selection of technique by measurement of fetal nuchal translucency. British Journal of Obstetrics and Gynaecology, 103, 887-890.
13. Sebire, N. J., Noble, P. L., Odibo, A., Malligianis, P., & Nicolaides, K. H. (1996). Single uterine entry for genetic amniocentesis in twin pregnancies. Ultrasound in Obstetrics and Gynecology, 7, 1-6.
14. Sepulveda, W., Sebire, N. J., Hughes, K., Odibo, A., & Nicolaides, K. H. (1996). The lambda sign at 10-14 weeks gestation as a predictor of chorionicity in twin pregnancies. Ultrasound in Obstetrics and Gynecology, 7, 421-423.
15. Snijders, R. M. J., Noble, P., Sebire, N., Souka, A., & Nicolaides, K. H. (1998). UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet, 351, 343-346.
16. Snijders, R. J. M., Sundberg, K., Holzgreve, W., Henry, G., & Nicolaides, K. H. (1999). Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstetrics and Gynecology 13, 167-170.
17. Snijders, R. J. M., Holzgreve, W., Cuckle, H., & Nicolaides, K. H. (1994). Maternal age-specific risks for trisomies at 9-14 weeks' gestation. Prenatal Diagnosis, 14, 543-552.
18. Spencer, K. (2000). Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCH and PAPP-A, combined with fetal nuchal translucency thickness. Prenatal Diagnosis, 20, 91-95.
19. Spencer, K., Salonen, R., & Muller, F. (1994). Down's syndrome screening in multiple pregnancies using alpha fetoprotein and free beta hCG. Prenatal Diagnosis, 14, 537-542.
20. Spencer, K., Souter, V., Tul, N., Snijders, R., & Nicolaides, K. H. (1999). A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound in Obstetrics and Gynecology, 13, 231-237.
21. Wald, N., Cuckle, H., Hu, T., & George, L. (1991). Maternal serum unconjugated oestriol and human chorionic gonadotropin levels in twin pregnancies: Implications for screening for Down's syndrome. British Journal of Obstetrics and Gynaecology, 98, 9008-9050.
22. Wapner, R. J., Johnson, A., Davis, G., Urban, A., Morgan, P., & Jackson, L. (1993). Prenatal diagnosis in twin gestations: A comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling. Obstetrics and Gynecology, 82, 49-56.
23. Wenstrom, K. D., Syrop, C. H., Hammitt, D. G., & Van-Voorhis, B. J. (1993). Increased risk of monochorionic twinning associated with assisted reproduction. Fertility and Sterility, 60, 510-514.